Documents potentially misleading in Aurobindo Pharma's Unit-VII: USFDA
Posted by
www.biotecnika.org
The FDA conducted a cGMP (Current Good Manufacturing Practices)
inspection at the Unit 7 manufacturing facility from September 19-27
this year.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/documents-potentially-misleading-in-aurobindo-pharmas-unit-vii-usfda/articleshow/71522222.cms
Subscribe to:
Post Comments (Atom)
Post a Comment